2024 NewAnescat Register

20 years ago, for the first time in Spain, a record was made of all the activity carried out by a medical speciality, called ANESCAT 2003. After 20 years, the increase in healthcare activity has exceeded the expectations and predictions that were made at the time. Therefore, it is necessary to make a new assessment of the work situation in which our speciality finds itself in order to be able to evaluate whether the increase in resources allocated has been proportional and therefore to be able to have objective data with a view to making new demands and planning future needs.

Study Overview

• Status: Recruiting
• Conditions: Anesthesia

• Study Type: Observational
• Enrollment (Estimated): 13634

Contacts and Locations

• Study Contact: Name: Carles Espinós, MD; Phone Number: 0034 650125113; Email: md071683@uic.es

Study Locations

• Spain
  • Barcelona
    • Barcelona, Barcelona, Spain, 08036
      • Recruiting
      • Hospital Clínic de Barcelona
      • Contact: Carles Espinós, MD; Phone Number: +34650125113; Email: md071683@uic.es

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

The study population is all patients involving anaesthetic activity during the study days (14 days in a year).

Description

The activity of all the areas in which the anaesthesiologist has some kind of work involvement over 24 hours during 14 days in a year is included through several questionnaires with different formats. Therefore all patients will be included without restriction criteria.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Anaesthesia surgical activity	The main outcome and objective of the study is to quantify all the anaesthesia activity	Assessed during the 14-day cut-off period of the study over one year
Anaesthesia activity in the Intensive Care Units	The main outcome and objective of the study is to quantify all the anaesthesia activity	Assessed during the 14-day cut-off period of the study over one year
Anaesthesia activity in the Chronic Pain Units	The main outcome and objective of the study is to quantify all the anaesthesia activity	Assessed during the 14-day cut-off period of the study over one year
Anaesthesia activity in the delivery rooms	The main outcome and objective of the study is to quantify all the anaesthesia activity	Assessed during the 14-day cut-off period of the study over one year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percentage of active staff in anaesthesiology services	With the aim of finding out the real needs of professionals in relation to medical activity	Assessed during the 14-day cut-off period of the study over one year
The role of anaesthesiology services in Catalonia with regard to polytrauma patients	The role of anaesthesiology services in Catalonia with regard to polytrauma patients	Assessed during the 14-day cut-off period of the study over one year
The role of anaesthesiology services in Catalonia with regard to cardiorespiratory arrest	The role of anaesthesiology services in Catalonia with regard to cardiorespiratory arrest	Assessed during the 14-day cut-off period of the study over one year

Collaborators and Investigators

• Sponsor: Consorci Sanitari de Terrassa
• Investigators: Principal Investigator: Carles Espinós, MD, Germans Trias i Pujol Hospital

Study record dates

Study Major Dates

• Study Start (Actual): May 4, 2025
• Primary Completion (Estimated): May 1, 2026
• Study Completion (Estimated): May 1, 2026

Study Registration Dates

• First Submitted: January 20, 2025
• First Submitted That Met QC Criteria: January 20, 2025
• First Posted (Actual): January 27, 2025

Study Record Updates

• Last Update Posted (Actual): February 4, 2026
• Last Update Submitted That Met QC Criteria: February 2, 2026
• Last Verified: February 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: PI-23-280

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No